CandidPharm · Ningbo Candid Pharmaceutical Co., Ltd. · 宁波嘉安药业有限公司
CATEGORY G · CP-PAYL-04Research compound

2-[(2S)-2-(Benzylamino)-3-phenylpropanamido]-5-iodobenzoic acid

2-[(2S)-2-(苄氨基)-3-苯基丙酰胺基]-5-碘苯甲酸
CAS Registry No.
1594094-64-0
Research application
CW-069 (HSET inhibitor)
Molecular Weight
500.3
Product Type
Research compound

Identification & Structure

Chemical structure of 2-[(2S)-2-(Benzylamino)-3-phenylpropanamido]-5-iodobenzoic acid
2D Structure

C1=CC=C(C=C1)C[C@@H](C(=O)NC2=C(C=C(C=C2)I)C(=O)O)NCC3=CC=CC=C3

Product CodeCP-PAYL-04
Product TypeResearch compound
CAS Number1594094-64-0
Molecular FormulaC23H21IN2O3
Molecular Weight500.3
IUPAC Name2-[[(2S)-2-(benzylamino)-3-phenylpropanoyl]amino]-5-iodobenzoic acid
SMILESC1=CC=C(C=C1)C[C@@H](C(=O)NC2=C(C=C(C=C2)I)C(=O)O)NCC3=CC=CC=C3
InChIKeyIRDIXDXDSUBHIU-NRFANRHFSA-N
PubChem CID73427517
Quality ParametersRequest current specification and available batch documentation

Research application

Research compound associated with CW-069 (HSET inhibitor).

Specifications and available documentation are reviewed against your project requirements. Availability and lead time are confirmed for each enquiry, taking current stock and production schedules into account.

Direct Inquiries

Request a Quote & Documents

Tell us the quantity, specification and destination. We will reply by email with pricing, lead time and the documents available.

· We will reply by email
· Mutual NDA available on request

Documents on Request

Request current specification and available batch documentation. We will confirm which TDS, SDS, CoA and analytical materials can be shared for this product.

Patent Notice

Supply is reviewed against the destination, patent status and intended use. Products are not offered where the transaction would infringe valid patents or supplementary protection certificates. Where applicable, regulatory-development activities may fall within the Bolar exemption under Article 10(6) of EU Directive 2001/83/EC, as amended by Directive 2004/27/EC, or 35 U.S.C. § 271(e)(1). These provisions have specific conditions; research use alone does not establish an exemption. Buyers must confirm applicable requirements for their jurisdiction and project before ordering. Commercial supply in protected territories requires an applicable legal basis.